Abstract:Protein neddylation is a ubiquitylation-like post-translational modification, catalyzed by a cascade consisting of three enzymes: NEDD8-activating enzyme E1 (NAE), an NEDD8-conjugating enzyme E2 (UBE2M or UBE2F), and NEDD8 E3 ligases. Cullin family proteins are the physiological substrates of neddylation, and Cullin neddylation activates Cullin-RING ligases (CRLs). CRLs are the largest ubiquitin E3 ligase family and mediate the ubiquitylation of similar to 20% cellular proteins to regulate many biological processes, including cell cycle, DNA damage response, cell growth, metabolism, survival, autophagy, migration, and immune escape. In the process of deneddylation, NEDD8 is hydrolyzed and removed from the substrate protein by specific deneddylation enzymes, and is released into cells to maintain the dynamic balance of the neddylation/ deneddylation. NEDD8 and NEDD8 enzymes are overexpressed or upregulated in a variety of cancers, leading to excessive activation of CRLs and subsequent degradation of many tumor suppressor proteins, thereby promoting the growth and survival of lung cancer cells, and lung tumorigenesis. Protein neddylation has been validated to be a promising target for anti-cancer therapy. Similarly, some deneddylation enzymes are highly expressed in lung cancer and their changes are also closely related to the growth and tumorigenesis of various malignant tumors, thus is a potential target for anti-cancer therapy. In this review, we mainly focus on the role of protein neddylation/ deneddylation in lung cancer, how the expression of neddylation and deneddylation pathways is changed in lung cancer cells, and how they regulate the growth and survival of lung cancer cells, as well as the lung tumor microenvironment and the related inflammatory/immune response. A better understanding of the role of key components of neddylation/deneddylation pathways in the promotion of lung cancer cell growth and tumorigenesis and establishment of lung tumor microenvironment will provide a sound rationale for targeting this pathway for effective lung cancer therapy.

Targeting cullin neddylation for cancer and fibrotic diseases

Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy

Anticancer Drug Discovery by Targeting Cullin Neddylation

Protein Neddylation and Its Alterations in Human Cancers for Targeted Therapy.

Discovery of small molecule inhibitors of neddylation catalyzing enzymes for anticancer therapy

Protein neddylation and its role in health and diseases

Protein Neddylation in Lung Tumorigenesis: Target Validation and Targeted Therapy

Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways

Neddylation promotes protein translocation between the cytoplasm and nucleus

Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway

Targeting Cullin-RING E3 ligases for anti-cancer therapy:efforts on drug discovery

Overactivated neddylation pathway as a therapeutic target in lung cancer

Suppression of tumor angiogenesis by targeting the protein neddylation pathway.

Neddylation-Independent Activities of MLN4924

Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions

Role of neddylation in neurological development and diseases

Neddylation of protein, a new strategy of protein post-translational modification for targeted treatment of central nervous system diseases

Neddylation and Deneddylation Enzymes in Regulation of Lung Tumorigenesis

Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review)

The neddylation-cullin 2-RBX1 E3 ligase axis targets tumor suppressor RhoB for degradation in liver cancer.

Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?